Tumor burden, as assessed by tumor volume (Fig. 4A) and weight (Fig. 4B), was significantly lower (p < 0.05) in the mice implanted with the WAVE3-deficient cells and the WAVE3-deficient re-expressing phospho-mutant PRD. Here, WASF3 is linked to neoplasm.